Delivery Order SPE2DB22D2007-SPE2DB25FJ5BZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,001.16 to AmerisourceBergen Drug Corp for the supply of Paclitaxel 300 mg/50 mL vials on August 14, 2025, with completion targeted for August 15, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.30 to AmerisourceBergen Drug Corp for the supply of Paclitaxel Protein-Bound 100mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $8,649.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $11,158.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on August 6, 2025, with completion scheduled for August 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $7,085.18 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on June 17, 2025, with an ultimate completion date of June 18, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Paclitaxel Protein-Bound 100mg, a chemotherapy medication. The delivery order, valued at $8,312.02 with a firm fixed price structure, carries an ultimate completion date of April 24, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- This delivery order, awarded on June 17, 2025, represents a $7,553.38 firm fixed price purchase of Paclitaxel Protein-Bound 100mg pharmaceutical product from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency (DLA), a Department of Defense component responsible for supply chain management across military operations and healthcare systems. The contract is unclassified as a set-aside and...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order on July 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver Docetaxel 160 mg/8 ml vials with a ceiling value of $2,267.90 and an ultimate completion date of July 25, 2025. The award is unclassified and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/8 mL vials with a ceiling value of $1,314.60. This delivery order, issued on September 11, 2025, represents a firm fixed-price procurement executed without any set-aside designation, indicating competitive award to the contractor based on open competition. The product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5BZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Paclitaxel 300 mg/50 ml vials with a firm fixed price ceiling value of $1,126.20. This delivery order represents a non-set-aside, competitively awarded procurement supporting the federal government's pharmaceutical supply requirements. The award is fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As the prime contractor on the SPE2DX vehicle, the company demonstrates substantial capacity to fulfill diverse pharmaceutical needs through its established track record of competitively awarded delivery orders across multiple therapeutic domains. The place of performance for this order is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/18/25 |